Cite

HARVARD Citation

    Fuchs, O. et al. (n.d.). High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients. Leukemia research. pp. S132-. [Online]. 
  
Back to record